Total Knee Athroplasty Neuropathic Pain: Difference between revisions

No edit summary
No edit summary
Line 7: Line 7:
</div>  
</div>  
== '''UNDER CONSTRUCTION 3.4.2024  '''Introduction ==
== '''UNDER CONSTRUCTION 3.4.2024  '''Introduction ==
Knee Replacement (KR) procedures are regularly performed now. However up to 1/5  of these replacements
Knee Replacement (KR) procedures are regularly performed now. However up to 1/5  of these replacements cause patients to have a degree of long-term pain or are not satisfied with their surgery.
 
cause patients to have a degree of long-term pain or are not satisfied with their surgery.  


== Sub Heading 2 ==
== Sub Heading 2 ==
Neuropathic pain rates post KJA reach their max at six to twelve weeks after surgery, and approximately 6% patients will go on to have neuropathiclong term neuropathic pain.
[[Neuropathic Pain|Neuropathic pain]] rates post KJA reach their max at six to twelve weeks after surgery, and approximately 6% patients will go on to have long term neuropathic pain.  
 
Post-surgical pain with a neuropathic component likely to be greater than pure nociceptive pain, poorly affecting QOL.
 
Neuropathic pain may stem from sensitisation of peripheral nociceptors many sources eg inflamed synovium, damaged subchondral bone, surgery trauma.  


Patients with a pre existing neuropathic pain elsewhere have a greater potential for chronic nociceptor stimulation and central pain transmission.
* Post-surgical pain with a neuropathic component is likely to be greater than pure nociceptive pain, affecting QOL.
* Neuropathic pain may stem from sensitisation of peripheral nociceptors many sources eg inflamed synovium, damaged subchondral bone, surgery trauma.
* Patients with a pre existing neuropathic pain elsewhere have a greater potential for chronic nociceptor stimulation and central pain transmission.


== Features ==
== Features ==
Neuropathic pain is distinguished by the following features: pain not relieved by rest
Neuropathic pain is distinguished by the following features: pain not relieved by rest and analgesia; diffuse and difficult to localise pain; pain that radiates towards or away from the knee; pain associated with feelings of pressure, numbness, sensitivity, burning, stinging, electric shocks or rigidity.
 
and analgesia; diffuse and difficult to localise pain; pain that radiates towards or away from the knee; pain associated with feelings of pressure, numbness, sensitivity, burning, stinging, electric shocks or rigidity.


== Assessing ==
== Assessing ==
Neuropathic pain can be assessed by various validated scoring systems, the most commonly used is the
Neuropathic pain can be assessed by various validated scoring systems, the most commonly used is the [[PainDETECT]], a helpful assessment tool in this patient group.
 
PainDETECT, a helpful assessment tool in this patient group.
 
There are UK NICE guidelines for the assessment and treatment of neuropathic pain. These include offering a choice of


amitriptyline, duloxetine, gabapentin or pregabalin as initial treatment. Capsaicin cream or topical lidocaine can be considered
Various guidelines exist for the assessment and treatment of neuropathic pain. These include offering a choice of


for people with localised neuropathic pain or neuroma
* Amitriptyline, duloxetine, gabapentin or pregabalin as initial treatment.
* Capsaicin cream or topical lidocaine is an option for localised neuropathic pain or neuroma


== Sub Heading 3 ==
== Sub Heading 3 ==

Revision as of 03:05, 4 April 2024


Original Editor - Lucinda hampton

Top Contributors - Lucinda hampton  

UNDER CONSTRUCTION 3.4.2024 Introduction[edit | edit source]

Knee Replacement (KR) procedures are regularly performed now. However up to 1/5 of these replacements cause patients to have a degree of long-term pain or are not satisfied with their surgery.

Sub Heading 2[edit | edit source]

Neuropathic pain rates post KJA reach their max at six to twelve weeks after surgery, and approximately 6% patients will go on to have long term neuropathic pain.

  • Post-surgical pain with a neuropathic component is likely to be greater than pure nociceptive pain, affecting QOL.
  • Neuropathic pain may stem from sensitisation of peripheral nociceptors many sources eg inflamed synovium, damaged subchondral bone, surgery trauma.
  • Patients with a pre existing neuropathic pain elsewhere have a greater potential for chronic nociceptor stimulation and central pain transmission.

Features[edit | edit source]

Neuropathic pain is distinguished by the following features: pain not relieved by rest and analgesia; diffuse and difficult to localise pain; pain that radiates towards or away from the knee; pain associated with feelings of pressure, numbness, sensitivity, burning, stinging, electric shocks or rigidity.

Assessing[edit | edit source]

Neuropathic pain can be assessed by various validated scoring systems, the most commonly used is the PainDETECT, a helpful assessment tool in this patient group.

Various guidelines exist for the assessment and treatment of neuropathic pain. These include offering a choice of

  • Amitriptyline, duloxetine, gabapentin or pregabalin as initial treatment.
  • Capsaicin cream or topical lidocaine is an option for localised neuropathic pain or neuroma

Sub Heading 3[edit | edit source]

Resources[edit | edit source]

  • bulleted list
  • x

or

  1. numbered list
  2. x

References[edit | edit source]